Literature DB >> 12010958

Immunity to murine chlamydial genital infection.

Richard P Morrison1, Harlan D Caldwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12010958      PMCID： PMC128027          DOI： 10.1128/IAI.70.6.2741-2751.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  115 in total

1.  Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin.

Authors:  H Su; N G Watkins; Y X Zhang; H D Caldwell
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium.

Authors:  D Nandi; J P Allison
Journal:  Reg Immunol       Date:  1993 Nov-Dec

5.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Role of Nramp1 deletion in Chlamydia infection in mice.

Authors:  S Pal; E M Peterson; L M de La Maza
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Behavioural and serological human immunodeficiency virus risk factors among female commercial sex workers in Cambodia.

Authors:  K Ohshige; S Morio; S Mizushima; K Kitamura; K Tajima; A Suyama; S Usuku; P Tia; L B Hor; S Heng; V Saphonn; O Tochikubo; K Soda
Journal:  Int J Epidemiol       Date:  2000-04       Impact factor: 7.196

8.  Chlamydial infection in inducible nitric oxide synthase knockout mice.

Authors:  J U Igietseme; L L Perry; G A Ananaba; I M Uriri; O O Ojior; S N Kumar; H D Caldwell
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

9.  CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway.

Authors:  P R Beatty; R S Stephens
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

10.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226
View more
  229 in total

1.  A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males.

Authors:  Sukumar Pal; Annahita K Sarcon; Luis M de la Maza
Journal:  Vaccine       Date:  2010-10-13       Impact factor: 3.641

2.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

Review 3.  New insights into a persistent problem -- chlamydial infections.

Authors:  Richard P Morrison
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation.

Authors:  Robert J Belland; David E Nelson; Dezso Virok; Deborah D Crane; Daniel Hogan; Daniel Sturdevant; Wandy L Beatty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

5.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

6.  Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics.

Authors:  Xiaoyun Liu; Mary Afrane; David E Clemmer; Guangming Zhong; David E Nelson
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

7.  Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.

Authors:  Weidang Li; Ashlesh K Murthy; M Neal Guentzel; James P Chambers; Thomas G Forsthuber; J Seshu; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

8.  Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Authors:  Gail L Sturdevant; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2014-04-10       Impact factor: 3.166

9.  Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.

Authors:  Delia F Tifrea; Sukumar Pal; Jean-Luc Popot; Melanie J Cocco; Luis M de la Maza
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

10.  Plasmid-mediated transformation tropism of chlamydial biovars.

Authors:  Lihua Song; John H Carlson; Bing Zhou; Kimmo Virtaneva; William M Whitmire; Gail L Sturdevant; Stephen F Porcella; Grant McClarty; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2013-11-11       Impact factor: 3.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.